 |
 |

The Syndrome of Lung Hemorrhage and Nephritis Is Usually an ANCA-Associated Condition
John L. Niles, MD;
Erwin P. Böttinger, MD;
Guillermo R. Saurina, MD;
K. J. Kelly, MD;
GuoLi Pan, MD;
A. Bernard Collins;
Robert T. McCluskey, MD
Arch Intern Med. 1996;156(4):440-445.
Abstract
Background In the absence of evidence of arteritis or Wegener's granulomatosis, the syndrome of lung hemorrhage and nephritis has been commonly associated with anti-glomerular basement membrane (GBM) antibodies. However, it has been increasingly recognized that many cases are associated with antineutrophil cytoplasmic antibodies (ANCAs).
Objective To review available clinical and pathologic findings to determine the diseases accounting for lung hemorrhage and nephritis.
Methods We studied the records of 750 patients from whom serum samples were sent to our laboratory for antiGBM antibody assays between 1981 and 1993 and found 88 patients with evidence of lung hemorrhage and nephritis. Serum samples were retested, using current methods, for anti-GBM antibodies (against noncollagenous 1 domain of the 3 chain of type IV collagen) and for antibodies to proteinase 3 and myeloperoxidase—the two types of ANCA of diagnostic value.
Results Of 88 patients with evidence of lung hemorrhage and nephritis, 48 had ANCAs, six had anti-GBM antibodies, and seven had both. In 48 patients with ANCAs, the pathologic findings that accounted for the pulmonary renal syndrome were pauci-immune necrotizing and crescentic glomerulonephritis and pulmonary capillaritis. Only eight had convincing evidence (during life) of Wegener's granulomatosis and only one other had documented arteritis. In 27 patients without ANCAs or anti-GBM antibodies, a variety of unrelated renal and pulmonary diseases were found.
Conclusions The largest group of patients who present with the syndrome of lung hemorrhage and nephritis have ANCAs and not anti-GBM antibodies. Appropriate tests for antibodies to proteinase 3, antibodies to myeloperoxidase, and anti-GBM antibodies provide reliable guides for making a diagnosis in patients with this pulmonary renal syndrome.
(Arch Intern Med. 1996;156:440-445)
Author Affiliations
From the Departments of Medicine (Drs Niles, Saurina, and Kelly) and Pathology (Drs Niles, McCluskey, and Pan and Mr Collins), Massachusetts General Hospital, Boston, and the National Cancer Institute, Bethesda, Md (Dr Böttinger).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Alveolar haemorrhage syndromes
Lazor
Orphan Lung Diseases 2011;1:15-31.
ABSTRACT
A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy
Merino et al.
Nephrol Dial Transplant 2011;26:1360-1366.
ABSTRACT
| FULL TEXT
Imaging of Pulmonary Vasculitis
Chung et al.
Radiology 2010;255:322-341.
ABSTRACT
| FULL TEXT
Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known
de Lind van Wijngaarden et al.
CJASN 2008;3:237-252.
ABSTRACT
| FULL TEXT
Beneficial Effect of Gabexate Mesilate on Microscopic Polyangiitis With Renal Dysfunction and Pulmonary Hemorrhage: A Case Report
Miyawaki et al.
ANGIOLOGY 2006;57:522-525.
ABSTRACT
Unusual Manifestation of Small-Vessel Vasculitis
Roemer et al.
Am. J. Roentgenol. 2006;186:586-587.
FULL TEXT
Small vessel vasculitis of the lung
Frankel et al.
Chronic Respiratory Disease 2005;2:75-84.
ABSTRACT
Imaging of the pulmonary manifestations of systemic disease
Rockall et al.
Postgrad. Med. J. 2001;77:621-638.
FULL TEXT
Rare diseases bullet 10: Small vessel vasculitis of the lung
Schwarz and Brown
Thorax 2000;55:502-510.
FULL TEXT
Tubulointerstitial nephritis with anti-neutrophil cytoplasmic antibody following indomethacin treatment
Sakai et al.
Nephrol Dial Transplant 1999;14:2774-2774.
FULL TEXT
Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis
Bosch
Ann Rheum Dis 1999;58:644-647.
ABSTRACT
| FULL TEXT
The pulmonary-renal syndrome: a poorly understood clinicopathologic condition
Bosch and Font
Lupus 1999;8:258-262.
ABSTRACT
|